Alkermes plc

Healthcare · Drug Manufacturers - Specialty & Generic · Ireland

Last price 45.34 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.61B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramu...